Position in CVM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$64
-$134 QoQ
Shares Held
62
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 41 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CVM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ROYAL BANK OF CANADA holds $2,116,187,680 across 427 Biotechnology names. CVM ranks #401 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
6,182,479 | $490,208,754 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
980,259 | $486,924,048 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
875,859 | $263,659,830 | |
| 4 | INCY |
Incyte Corp
|
1,132,050 | $128,329,182 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
174,515 | $108,817,078 | |
| 6 | MRNA |
Moderna, Inc.
|
944,457 | $66,140,319 | |
| 7 | INSM |
INSMED Inc
|
416,487 | $44,405,840 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
545,761 | $42,716,712 |
All Filings in CVM
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $64 | 62 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $198 | 62 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $326 | 62 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $570 | 62 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $409 | 179 | Shares | Defined | 2025-11-21 | |
| 2025-03-31 | $432 | 1,883 | Shares | Defined | 2025-11-21 | |
| 2024-12-31 | $16,598 | 41,500 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $6,888 | 6,500 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,739 | 1,500 | Shares | Defined | 2024-11-06 | |
| 2024-03-31 | $2,864 | 1,500 | Shares | Defined | 2024-11-05 | |
| 2023-12-31 | $14,887 | 5,474 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,930 | 1,545 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $6,216 | 2,580 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,490 | 1,505 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,535 | 1,505 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $7,152 | 2,315 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $6,492 | 1,443 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $18,663 | 4,749 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $87,066 | 12,263 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $73,269 | 6,667 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $69,769 | 8,038 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $59,348 | 3,902 | Shares | Defined | 2021-07-20 | |
| 2020-12-31 | $54,603 | 4,683 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $45,377 | 3,559 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $55,576 | 3,725 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $42,767 | 3,706 | Shares | Defined | 2020-06-16 | |
| No filing history on record for this holder in this stock. | ||||||